T. Rowe Price files 13G on Elanco; sole voting 31,482,581
Rhea-AI Filing Summary
T. Rowe Price Investment Management, Inc. filed a Schedule 13G reporting beneficial ownership of 31,547,970 shares (6.4%) of Elanco Animal Health common stock as of 09/30/2025.
The filer reports sole voting power over 31,482,581 shares and sole dispositive power over 31,547,970 shares, with no shared voting or dispositive power. It certifies the holdings were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Positive
- None.
Negative
- None.